The UK’s Telegraph (4/8, Gray) reports, “A vaccine that can train cancer patients’ own bodies to seek out and destroy tumour cells has been developed by scientists. The therapy, which targets a molecule found in 90 per cent of all cancers, could provide a universal injection that allows patients’ immune systems to fight off common cancers including breast and prostate cancer.” The Telegraph notes that “the new vaccine, developed by drug company Vaxil Biotheraputics along with researchers at Tel Aviv University, uses a small section of the molecule to prime the immune system so that it can identify and destroy cancer cells.”
